Safety and Efficacy of Mupirocin Gel in Children With Impetigo
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to show non inferiority in terms of safety and efficacy of
topical administration BID (Twice daily) of Mupirocin Gel 20 mg/g compared to topical
administration of Mupirocin Ointment 20 mg/g TID (three times daily) (Bactroban) in the
treatment of impetigo in paediatric population.